-- The randomized, double-blind, placebo-controlled Phase III study with RHB-102 for acute gastroenteritis and gastritis (the GUARD study) is... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=53907
Eagle Pharmaceuticals, announced positive results from a recently-conducted clinical trial of its bendamustine hydrochloride (HCl) product, in... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=85068&sid=2
Sarepta Therapeutics, a developer of innovative RNA-based therapeutics, provided an update on its discussions with the US Food and Drug... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=84810&sid=2
SOPHIA ANTIPOLIS, France, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=47000
From the Wires Oct. 17, 2014 08:28 PM NEW YORK , Oct. 17, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law... ...http://in.sys-con.com/node/3213653
Abercrombie and Fitch...
Distribuidora García, empresa...